• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion

tetano

Editor, Senior Moderator
J Med Virol


. 2024 Mar;96(3):e29545.
doi: 10.1002/jmv.29545. Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion

Xiao Fu[SUP] 1 2 3 [/SUP], Zhujian Wang[SUP] 4 [/SUP], Binjun Chen[SUP] 1 2 3 [/SUP], Haojie Sun[SUP] 1 2 3 [/SUP], Jihan Lyu[SUP] 1 2 3 [/SUP], Jing Shao[SUP] 5 [/SUP], Xiaoling Lu[SUP] 1 2 3 [/SUP], Jianghong Xu[SUP] 1 2 3 [/SUP], Juanmei Yang[SUP] 1 2 3 [/SUP], Fanglu Chi[SUP] 1 2 3 [/SUP], Yibo Huang[SUP] 1 2 3 [/SUP], Dongdong Ren[SUP] 1 2 3 [/SUP]



Affiliations
Abstract

A large-scale outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) occurred in Shanghai, China, in early December 2022. To study the incidence and characteristics of otitis media with effusion (OME) complicating SARS-CoV-2, we collected 267 middle ear effusion (MEE) samples and 172 nasopharyngeal (NP) swabs from patients. The SARS-CoV-2 virus was detected by RT-PCR targeting. The SARS-CoV-2 virus, angiotensin-converting enzyme 2 (ACE2), and transmembrane serine protease 2 (TMPRSS2) expression in human samples was examined via immunofluorescence. During the COVID-19 epidemic in 2022, the incidence of OME (3%) significantly increased compared to the same period from 2020 to 2022. Ear symptoms in patients with SARS-CoV-2 complicated by OME generally appeared late, even after a negative NP swab, an average of 9.33 ± 6.272 days after COVID-19 infection. The SARS-CoV-2 virus was detected in MEE, which had a higher viral load than NP swabs. The insertion rate of tympanostomy tubes was not significantly higher than in OME patients in 2019-2022. Virus migration led to high viral loads in MEE despite negative NP swabs, indicating that OME lagged behind respiratory infections but had a favorable prognosis. Furthermore, middle ear tissue from adult humans coexpressed the ACE2 receptor for the SARS-CoV-2 virus and the TMPRSS2 cofactors required for virus entry.

Keywords: biostatistics & bioinformatics, RNA extraction; biostatistics & bioinformatics, data processing; coronavirus; research and analysis methods; virus classification, data acquisition.

 
Back
Top Bottom